NASDAQ
Cue Biopharma, Inc. (CUE) has a free cash flow growth of -928.16% as of Friday, May 29, 2026. This represents a 48643.84% decrease compared to its 12-month average of -1.90%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.